British Medical Journal
Predictors of remission in acromegaly on octreotide lar
By Z.Yu. Khalimova and S.S. Issaeva.
Abstract
Long-acting somatostatin analogues (SSAs) are the mainstay of first-line andadjuvant medical therapy in acromegaly, yet biochemical control is achieved at markedly variablerates and over unpredictable timeframes across published cohorts. Reliable, readily availablepredictors of who will remit, and how quickly, remain incompletely defined.
Keywords
- Pituitary Gland Disorders and Treatments
- acromegaly
- somatostatin analogues
- remission
- predictors of remission
- biochemical control
- growth hormone
- insulin-like growth factor I
- Open access
Source
Published in British Medical Journal. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.